Back to Journals » Neuropsychiatric Disease and Treatment » Volume 9

Neuropsychiatric Disease and Treatment


Archive: Volume 9, 2013

Salivary alpha-amylase and cortisol responsiveness following electrically stimulated physical stress in bipolar disorder patients

Tanaka Y, Maruyama Y, Ishitobi Y, Kawano A, Ando T, Ikeda R, Inoue A, Imanaga J, Okamoto S, Kanehisa M, Ninomiya T, Tsuru J, Akiyoshi J

Neuropsychiatric Disease and Treatment 2013, 9:1899-1905

Published Date: 6 December 2013

Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia

Takahashi N, Takahashi M, Saito T, Iizumi M, Saito Y, Shimizu H, Matsumura T

Neuropsychiatric Disease and Treatment 2013, 9:1889-1898

Published Date: 6 December 2013

Navigated transcranial magnetic stimulation in preoperative planning for the treatment of motor area cavernous angiomas

Paiva WS, Fonoff ET, Marcolin MA, Bor-Seng-Shu E, Figueiredo EG, Teixeira MJ

Neuropsychiatric Disease and Treatment 2013, 9:1885-1888

Published Date: 9 December 2013

22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis

Squarcione C, Torti MC, Di Fabio F, Biondi M

Neuropsychiatric Disease and Treatment 2013, 9:1873-1884

Published Date: 4 December 2013

Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study

Shimizu H, Takebayashi M, Tani M, Tanaka H, Yamagata B, Kurosawa K, Yamada H, Hachisu M, Hisaoka-Nakashima K, Okada-Tsuchioka M, Mimura M, Iwanami A

Neuropsychiatric Disease and Treatment 2013, 9:1867-1872

Published Date: 6 December 2013

Current clinical application of deep-brain stimulation for essential tremor

Chopra A, Klassen BT, Stead M

Neuropsychiatric Disease and Treatment 2013, 9:1859-1865

Published Date: 2 December 2013

Olfactory functions are not associated with autism severity in autism spectrum disorders

Dudova I, Hrdlicka M

Neuropsychiatric Disease and Treatment 2013, 9:1847-1851

Published Date: 27 November 2013

Adjunctive enteral phenobarbital for adult status epilepticus: a brief report

Tiamkao S, Suttapan K, Pranbul S, Tiamkao S, Sawanyawisuth K, Integrated Epilepsy Research group

Neuropsychiatric Disease and Treatment 2013, 9:1829-1834

Published Date: 26 November 2013

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt

El-Tallawy HN, Farghaly WM, Shehata GA, Rageh TA, Abdel Hakeem NM, Abd Al Hamed M, Badry R

Neuropsychiatric Disease and Treatment 2013, 9:1821-1826

Published Date: 26 November 2013

Asperger syndrome related suicidal behavior: two case studies

Kocourkova J, Dudova I, Koutek J

Neuropsychiatric Disease and Treatment 2013, 9:1815-1819

Published Date: 22 November 2013

Duloxetine in panic disorder with somatic gastric pain

Preve M, Nisita C, Bellini M, Dell'Osso L

Neuropsychiatric Disease and Treatment 2013, 9:1811-1813

Published Date: 21 November 2013

Effectiveness and safety of Nintendo Wii Fit PlusTM training in children with migraine without aura: a preliminary study

Esposito M, Ruberto M, Gimigliano F, Marotta R, Gallai B, Parisi L, Lavano SM, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1803-1810

Published Date: 15 November 2013

Early resorption of an artificial bone graft made of calcium phosphate for cranioplasty: case report

Monaco BA, Fonoff ET, Teixeira MJ

Neuropsychiatric Disease and Treatment 2013, 9:1801-1802

Published Date: 15 November 2013

Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey

Yüce M, Zoroglu SS, Ceylan MF, Kandemir H, Karabekiroglu K

Neuropsychiatric Disease and Treatment 2013, 9:1791-1799

Published Date: 14 November 2013

Epidemiology of nonfatal stroke and transient ischemic attack in Al-Kharga District, New Valley, Egypt

Farghaly WM, El-Tallawy HN, Shehata GA, Rageh TA, Abdel-Hakeem NM, Elhamed MA, Al-Fawal BM, Badry R

Neuropsychiatric Disease and Treatment 2013, 9:1785-1790

Published Date: 18 November 2013

Brain volumes and neuropsychological performance are related to current smoking and alcoholism history

Luhar RB, Sawyer KS, Gravitz Z, Ruiz SM, Oscar-Berman M

Neuropsychiatric Disease and Treatment 2013, 9:1767-1784

Published Date: 12 November 2013

Effects of ozone applied by spinal endoscopy in patients with chronic pain related to failed back surgery syndrome: a pilot study

Magalhães FNO, Soares SC, Torres JM, Ungaretti A, Cacciacarro MF, Teixeira MJ, Fonoff ET

Neuropsychiatric Disease and Treatment 2013, 9:1759-1766

Published Date: 12 November 2013

Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry

Suttajit S, Paholpak S, Choovanicvong S, Kittiwattanagul K, Pratoomsri W, Srisurapanont M

Neuropsychiatric Disease and Treatment 2013, 9:1751-1757

Published Date: 11 November 2013

Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses

Ciudad A, Anand E, Berggren L, Casillas M, Schacht A, Perrin E

Neuropsychiatric Disease and Treatment 2013, 9:1737-1750

Published Date: 8 November 2013

Risk factors for fatal and nonfatal repetition of suicide attempts: a literature review

Beghi M, Rosenbaum JF, Cerri C, Cornaggia CM

Neuropsychiatric Disease and Treatment 2013, 9:1725-1736

Published Date: 8 November 2013

Quality of Web-based information on obsessive compulsive disorder

Klila H, Chatton A, Zermatten A, Khan R, Preisig M, Khazaal Y

Neuropsychiatric Disease and Treatment 2013, 9:1717-1723

Published Date: 5 November 2013

The role of the serotonergic system in suicidal behavior

Sadkowski M, Dennis B, Clayden RC, ElSheikh W, Rangarajan S, DeJesus J, Samaan Z

Neuropsychiatric Disease and Treatment 2013, 9:1699-1716

Published Date: 6 November 2013

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K

Neuropsychiatric Disease and Treatment 2013, 9:1683-1698

Published Date: 1 November 2013

Identification of common predictors of surgical outcomes for epilepsy surgery

Zhang J, Liu W, Chen H, Xia H, Zhou Z, Mei S, Liu Q, Li Y

Neuropsychiatric Disease and Treatment 2013, 9:1673-1682

Published Date: 6 November 2013

Sodium valproate-induced enuresis in a pediatric bipolar patient

Cheng W, Lin X, Lu D

Neuropsychiatric Disease and Treatment 2013, 9:1671-1672

Published Date: 31 October 2013

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients

Zou C, Ding X, Flaherty JH, Dong BR

Neuropsychiatric Disease and Treatment 2013, 9:1661-1670

Published Date: 1 November 2013

Cognitive functioning correlates of self-esteem and health locus of control in schizophrenia

Wang CS, Wu JYW, Chang WC, Chuang SP

Neuropsychiatric Disease and Treatment 2013, 9:1647-1654

Published Date: 29 October 2013

Let’s get back to work: survival analysis on the return-to-work after depression

Vemer P, Bouwmans CA, Zijlstra-Vlasveld MC, van der Feltz-Cornelis CM, Hakkaart-van Roijen L

Neuropsychiatric Disease and Treatment 2013, 9:1637-1645

Published Date: 25 October 2013

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments

Bargiotas P, Konitsiotis S

Neuropsychiatric Disease and Treatment 2013, 9:1605-1617

Published Date: 22 October 2013

Agomelatine as monotherapy for major depression: an outpatient, open-label study

Pecenak J, Novotny V

Neuropsychiatric Disease and Treatment 2013, 9:1595-1604

Published Date: 22 October 2013

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report

Kitaichi Y, Inoue T, Mitsui N, Nakagawa S, Kameyama R, Hayashishita Y, Shiga T, Kusumi I, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:1591-1594

Published Date: 17 October 2013

Selective cognitive empathy deficit in adolescents with restrictive anorexia nervosa

Calderoni S, Fantozzi P, Maestro S, Brunori E, Narzisi A, Balboni G, Muratori F

Neuropsychiatric Disease and Treatment 2013, 9:1583-1589

Published Date: 16 October 2013

Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients

Yoshimura B, Hirota T, Takaki M, Kishi Y

Neuropsychiatric Disease and Treatment 2013, 9:1565-1571

Published Date: 10 October 2013

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia

Hirano J, Watanabe K, Suzuki T, Uchida H, Den R, Kishimoto T, Nagasawa T, Tomita Y, Hara K, Ochi H, Kobayashi Y, Ishii M, Fujita A, Kanai Y, Goto M, Hayashi H, Inamura K, Ooshima F, Sumida M, Ozawa T, Sekigawa K, Nagaoka M, Yoshimura K, Konishi M, Inagaki A, Saito T, Motohashi N, Mimura M, Okubo Y, Kato M

Neuropsychiatric Disease and Treatment 2013, 9:1553-1564

Published Date: 11 October 2013

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

Ünsal C, Albayrak Y, Albayrak N, Kuloğlu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2013, 9:1545-1552

Published Date: 11 October 2013

Spirituality in childhood cancer care

Lima NN, do Nascimento VB, de Carvalho SM, Neto ML, Moreira MM, Brasil AQ, Celestino Junior FT, de Oliveira GF, Reis AO

Neuropsychiatric Disease and Treatment 2013, 9:1539-1544

Published Date: 9 October 2013

Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia

Ünsal C, Oran M, Tureli HO, Alpsoy S, Yeşilyurt S, Arslan M, Topcu B, Karakaya O, Kurt E

Neuropsychiatric Disease and Treatment 2013, 9:1531-1537

Published Date: 8 October 2013

Lurasidone as a potential therapy for bipolar disorder

Woo YS, Wang HR, Bahk WM

Neuropsychiatric Disease and Treatment 2013, 9:1521-1529

Published Date: 8 October 2013

Attachment styles in children affected by migraine without aura

Esposito M, Parisi L, Gallai B, Marotta R, Di Dona A, Lavano SM, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1513-1519

Published Date: 3 October 2013

Right putamen hemorrhage manifesting as apraxia of eyelid opening

Lin YH, Liou LM, Lai CL, Chang YP

Neuropsychiatric Disease and Treatment 2013, 9:1495-1497

Published Date: 26 September 2013

Persisting primitive reflexes in medication-naïve girls with attention-deficit and hyperactivity disorder

Konicarova J, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2013, 9:1457-1461

Published Date: 20 September 2013

Behavioral symptoms related to cognitive impairment

Dillon C, Serrano CM, Castro D, Pérez Leguizamón P, Heisecke SL, Taragano FE

Neuropsychiatric Disease and Treatment 2013, 9:1443-1455

Published Date: 19 September 2013

Psychomotor approach in children affected by nonretentive fecal soiling (FNRFS): a new rehabilitative purpose

Esposito M, Gimigliano F, Ruberto M, Marotta R, Gallai B, Parisi L, Lavano SM, Mazzotta G, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1433-1441

Published Date: 19 September 2013

The Impact of Event Scale – Revised: psychometric properties of the Italian version in a sample of flood victims

Craparo G, Faraci P, Rotondo G, Gori A

Neuropsychiatric Disease and Treatment 2013, 9:1427-1432

Published Date: 19 September 2013

Childhood depression: a systematic review

Lima NNR, Nascimento VB, Carvalho SMF, Abreu LC, Neto MLR, Brasil AQ, Celestino Junior FT, Oliveira GF, Reis AOA

Neuropsychiatric Disease and Treatment 2013, 9:1417-1425

Published Date: 19 September 2013

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease

Kano O, Urita Y, Ito H, Takazawa T, Kawase Y, Murata K, Hirayama T, Miura K, Ishikawa Y, Kiyozuka T, Aoyagi J, Iwasaki Y

Neuropsychiatric Disease and Treatment 2013, 9:1411-1415

Published Date: 18 September 2013

Saccadic eye movement applications for psychiatric disorders

Bittencourt J, Velasques B, Teixeira S, Basile LF, Salles JI, Nardi AE, Budde H, Cagy M, Piedade R, Ribeiro P

Neuropsychiatric Disease and Treatment 2013, 9:1393-1409

Published Date: 16 September 2013

Treatment of neurolept-induced tardive dyskinesia

Jankelowitz SK

Neuropsychiatric Disease and Treatment 2013, 9:1371-1380

Published Date: 16 September 2013

Confusion assessment method: a systematic review and meta-analysis of diagnostic accuracy

Shi Q, Warren L, Saposnik G, MacDermid JC

Neuropsychiatric Disease and Treatment 2013, 9:1359-1370

Published Date: 19 September 2013

Maternal personality profile of children affected by migraine

Esposito M, Roccella M, Gallai B, Parisi L, Lavano SM, Marotta R, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1351-1358

Published Date: 11 September 2013

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

Castrop F, Haslinger B, Hemmer B, Buck D

Neuropsychiatric Disease and Treatment 2013, 9:1339-1349

Published Date: 16 September 2013

Safety of escitalopram in pregnancy: a case series

Bellantuono C, Bozzi F, Orsolini L

Neuropsychiatric Disease and Treatment 2013, 9:1333-1337

Published Date: 9 September 2013

Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects

El-Tallawy H, Farghaly W, Metwally N, Rageh T, Shehata GA, Badry R, El Moselhy E, Hassan M, Sayed MM, Abdelwarith AA, Hamed Y, Shaaban I, Mohamed T, Abd El Hamed M, Kandil MR

Neuropsychiatric Disease and Treatment 2013, 9:1295-1300

Published Date: 9 September 2013

Clozapine reinitiation following a "red result" secondary to chemotherapy

Munshi T, Mazhar M, Hassan T

Neuropsychiatric Disease and Treatment 2013, 9:1267-1271

Published Date: 27 August 2013

The use of psychotropic medication during pregnancy: how about the newborn?

Kieviet N, Dolman KM, Honig A

Neuropsychiatric Disease and Treatment 2013, 9:1257-1266

Published Date: 28 August 2013

Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand

Leelahanaj T, Kongsakon R, Choovanichvong S, Tangwongchai S, Paholpak S, Kongsuk T, Srisurapanont M

Neuropsychiatric Disease and Treatment 2013, 9:1249-1256

Published Date: 22 August 2013

A discriminated conditioned punishment model of phobia

Bloom CM, Post RJ, Mazick J, Blumenthal B, Doyle C, Peters B, Dyche J, Davenport DG

Neuropsychiatric Disease and Treatment 2013, 9:1239-1248

Published Date: 21 August 2013

Occlusal traits in developmental dyslexia: a preliminary study

Perillo L, Esposito M, Contiello M, Lucchese A, Santini AC, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1231-1237

Published Date: 22 August 2013

Age as a factor in sensory integration function in Taiwanese children [Corrigendum]

Lin CK, Wu HM, Wang HY, Tseng MH, Lin CH

Neuropsychiatric Disease and Treatment 2013, 9:1221-1222

Published Date: 19 August 2013

Celiac plexus neurolysis for the treatment of upper abdominal cancer pain

Teixeira MJ, Neto ER, Marinho da Nobrega JC, Angelos JS, Martin MS, Monaco BA, Fonoff ET

Neuropsychiatric Disease and Treatment 2013, 9:1209-1212

Published Date: 19 August 2013

Quality of life and personality traits in patients with malignant pleural mesothelioma and their first-degree caregivers

Granieri A, Tamburello S, Tamburello A, Casale S, Cont C, Guglielmucci F, Innamorati M

Neuropsychiatric Disease and Treatment 2013, 9:1193-1202

Published Date: 14 August 2013

Temperamental characteristics in childhood migraine without aura: a multicenter study

Esposito M, Marotta R, Gallai B, Parisi L, Patriciello G, Lavano SM, Mazzotta G, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1187-1192

Published Date: 13 August 2013

Latent class analysis of reading, decoding, and writing performance using the Academic Performance Test: concurrent and discriminating validity

Cogo-Moreira H, Carvalho CAF, Kida ASB, de Avila CRB, Salum GA, Moriyama TS, Gadelha A, Rohde LA, Moura LM, Jackowski AP, Mari JJ

Neuropsychiatric Disease and Treatment 2013, 9:1175-1185

Published Date: 14 August 2013

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey

Olivares JM, Thirunavukarasu M, Kulkarni J, Zang HY, Zhang M, Zhang F

Neuropsychiatric Disease and Treatment 2013, 9:1163-1170

Published Date: 12 August 2013

A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients

Chen LF, Lin CE, Chou YC, Mao WC, Chen YC, Tzeng NS

Neuropsychiatric Disease and Treatment 2013, 9:1159-1162

Published Date: 9 August 2013

Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders

Bersani G, Polli E, Valeriani G, Zullo D, Melcore C, Capra E, Quartini A, Marino P, Minichino A, Bernabei L, Robiony M, Bersani FS, Liberati D

Neuropsychiatric Disease and Treatment 2013, 9:1137-1144

Published Date: 8 August 2013

Mental health system in Saudi Arabia: an overview

Qureshi NA, Al-Habeeb AA, Koenig HG

Neuropsychiatric Disease and Treatment 2013, 9:1121-1135

Published Date: 8 August 2013

Novel glutamatergic drugs for the treatment of mood disorders

Lapidus KAB, Soleimani L, Murrough JW

Neuropsychiatric Disease and Treatment 2013, 9:1101-1112

Published Date: 7 August 2013

Clinical features and imaging findings in a case of Capgras syndrome

Luca M, Bordone A, Luca A, Patti A, Sortino G, Calandra C

Neuropsychiatric Disease and Treatment 2013, 9:1095-1099

Published Date: 6 August 2013

Executive dysfunction in children affected by obstructive sleep apnea syndrome: an observational study

Esposito M, Antinolfi L, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Mazzotta G, Precenzano F, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1087-1094

Published Date: 9 August 2013

A case of early onset Parkinson's disease after major stress

Zou K, Guo W, Tang G, Zheng B, Zheng Z

Neuropsychiatric Disease and Treatment 2013, 9:1067-1069

Published Date: 2 August 2013

Self-concept evaluation and migraine without aura in childhood

Esposito M, Gallai B, Parisi L, Castaldo L, Marotta R, Lavano SM, Mazzotta G, Roccella M, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:1061-1066

Published Date: 5 August 2013

Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression

Sozeri-Varma G, Kalkan-Oguzhanoglu N, Efe M, Kiroglu Y, Duman T

Neuropsychiatric Disease and Treatment 2013, 9:1053-1059

Published Date: 12 August 2013

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease

Klimkowicz-Mrowiec A, Wolkow P, Sado M, Dziubek A, Pera J, Dziedzic T, Szczudlik A, Slowik A

Neuropsychiatric Disease and Treatment 2013, 9:1029-1033

Published Date: 29 July 2013

MicroRNA as therapeutic targets for treatment of depression

Hansen KF, Obrietan K

Neuropsychiatric Disease and Treatment 2013, 9:1011-1021

Published Date: 29 July 2013

Presurgical EEG-fMRI in a complex clinical case with seizure recurrence after epilepsy surgery

Zhang J, Liu Q, Mei S, Zhang X, Wang X, Liu W, Chen H, Xia H, Zhou Z, Li Y

Neuropsychiatric Disease and Treatment 2013, 9:1003-1010

Published Date: 26 July 2013

Age as a factor in sensory integration function in Taiwanese children

Lin CK, Wu HM, Wang HY, Tseng MH, Lin CH.

Neuropsychiatric Disease and Treatment 2013, 9:995-1001

Published Date: 25 July 2013

Update on optimal use of lisdexamfetamine in the treatment of ADHD

Madaan V, Kolli V, Bestha DP, Shah MJ

Neuropsychiatric Disease and Treatment 2013, 9:977-983

Published Date: 22 July 2013

Reduced dorsolateral prefrontal cortical hemodynamic response in adult obsessive-compulsive disorder as measured by near-infrared spectroscopy during the verbal fluency task

Hirosawa R, Narumoto J, Sakai Y, Nishida S, Ishida T, Nakamae T, Takei Y, Fukui K

Neuropsychiatric Disease and Treatment 2013, 9:955-962

Published Date: 11 July 2013

The efficacy of Li in bipolar disorder

Lozano R, Marín R, Santacruz MJ, Freire I, Gomez R

Neuropsychiatric Disease and Treatment 2013, 9:953-954

Published Date: 11 July 2013

Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment

Ozkan S, Adapinar DO, Elmaci NT, Arslantas D

Neuropsychiatric Disease and Treatment 2013, 9:947-951

Published Date: 9 July 2013

Acute parietal lobe infarction presenting as Gerstmann’s syndrome and cognitive decline mimicking senile dementia

Chen TY, Chen CY, Yen CH, Kuo SC, Yeh YW, Chang S, Huang SY

Neuropsychiatric Disease and Treatment 2013, 9:937-940

Published Date: 3 July 2013

Visuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged children

Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Mazzotta G, Patriciello G, Precenzano F, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:921-926

Published Date: 26 June 2013

Is placebo useful in the treatment of major depression in clinical practice?

Marchesi C, De Panfilis C, Tonna M, Ossola P

Neuropsychiatric Disease and Treatment 2013, 9:915-920

Published Date: 25 June 2013

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis

Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M

Neuropsychiatric Disease and Treatment 2013, 9:893-914

Published Date: 24 June 2013

Pregabalin for the treatment of generalized anxiety disorder: an update

Baldwin DS, Ajel K, Masdrakis VG, Nowak M, Rafiq R

Neuropsychiatric Disease and Treatment 2013, 9:883-892

Published Date: 24 June 2013

Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ

Bae SO, Kim MD, Lee JG, Seo JS, Won SH, Woo YS, Seok JH, Kim W, Kim SJ, Min KJ, Jon DI, Shin YC, Bahk WM, Yoon BH

Neuropsychiatric Disease and Treatment 2013, 9:869-874

Published Date: 24 June 2013

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia

Washida K, Takeda T, Habara T, Sato S, Oka T, Tanaka M, Yoshimura Y, Aoki S

Neuropsychiatric Disease and Treatment 2013, 9:861-868

Published Date: 19 June 2013

A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania

Chen J, Lu Z, Zhang M, Zhang J, Ni X, Jiang X, Xu H, Heeramun-Aubeeluck A, Hu Q, Jin H, Davis JM

Neuropsychiatric Disease and Treatment 2013, 9:839-845

Published Date: 17 June 2013

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ

Neuropsychiatric Disease and Treatment 2013, 9:815-822

Published Date: 14 June 2013

Balance and gait in older electroconvulsive therapy recipients: a pilot study

Plakiotis C, Barson F, Vengadasalam B, Haines TP, O'Connor DW

Neuropsychiatric Disease and Treatment 2013, 9:805-812

Published Date: 5 June 2013

The cost of schizophrenia in Japan

Sado M, Inagaki A, Koreki A, Knapp M, Kissane LA, Mimura M, Yoshimura K

Neuropsychiatric Disease and Treatment 2013, 9:787-798

Published Date: 30 May 2013

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder

Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N

Neuropsychiatric Disease and Treatment 2013, 9:781-786

Published Date: 5 June 2013

Treatment in hospital for alcohol-dependent patients decreases attentional bias

Flaudias V, Brousse G, de Chazeron I, Planche F, Brun J, Llorca PM

Neuropsychiatric Disease and Treatment 2013, 9:773-779

Published Date: 30 May 2013

Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt

El Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Badry R, Metwally NA, El Moselhy EA, Hassan M, Sayed MA, Waris AA, Hamed Y, Shaaban I, Hamed MA, Kandil MR

Neuropsychiatric Disease and Treatment 2013, 9:767-771

Published Date: 27 May 2013

Psychomotor retardation and externally oriented thinking in major depression

Luca M, Luca A, Calandra C

Neuropsychiatric Disease and Treatment 2013, 9:759-766

Published Date: 27 May 2013

The impact of limbic system morphology on facial emotion recognition in bipolar I disorder and healthy controls

Bio DS, Soeiro-de-Souza MG, Otaduy MCG, Machado-Vieira R, Moreno RA

Neuropsychiatric Disease and Treatment 2013, 9:743-751

Published Date: 23 May 2013

A validation study of the Chinese-Cantonese Addenbrooke’s Cognitive Examination Revised (C-ACER)

Wong LL, Chan CC, Leung JL, Yung CY, Wu KK, Cheung SYY, Lam CLM

Neuropsychiatric Disease and Treatment 2013, 9:731-737

Published Date: 7 June 2013

Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose

Samtani MN, Nuamah I, Gopal S, Remmerie B, Sliwa JK, Alphs L

Neuropsychiatric Disease and Treatment 2013, 9:721-730

Published Date: 20 May 2013

Preventive treatment in migraine and the new US guidelines

Estemalik E, Tepper S

Neuropsychiatric Disease and Treatment 2013, 9:709-720

Published Date: 17 May 2013

Magnetic resonance spectroscopy in Alzheimer’s disease

Graff-Radford J, Kantarci K

Neuropsychiatric Disease and Treatment 2013, 9:687-696

Published Date: 16 May 2013

Reduced prefrontal cortex activation using the Trail Making Test in schizophrenia

Fujiki R, Morita K, Sato M, Kamada Y, Kato Y, Inoue M, Shoji Y, Uchimura N

Neuropsychiatric Disease and Treatment 2013, 9:675-685

Published Date: 16 May 2013

Epilepsy and homicide

Pandya NS, Vrbancic M, Ladino LD, Tellez-Zenteno JF

Neuropsychiatric Disease and Treatment 2013, 9:667-673

Published Date: 14 May 2013

Association between leptin and delirium in elderly inpatients

Sanchez JC, Ospina JP, Gonzalez MI

Neuropsychiatric Disease and Treatment 2013, 9:659-666

Published Date: 13 May 2013

Differences between bipolar and unipolar depression on Rorschach testing

Kimura H, Osaki A, Kawashima R, Inoue T, Nakagawa S, Suzuki K, Asakura S, Tanaka T, Kitaichi Y, Masui T, Kitagawa N, Kako Y, Abekawa T, Kusumi I, Yamanaka H, Denda K, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:619-627

Published Date: 7 May 2013

Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia

Battaglia G, Alesi M, Inguglia M, Roccella M, Caramazza G, Bellafiore M, Palma A

Neuropsychiatric Disease and Treatment 2013, 9:595-603

Published Date: 3 May 2013

Profile of blonanserin for the treatment of schizophrenia

Tenjin T, Miyamoto S, Ninomiya Y, Kitajima R, Ogino S, Miyake N, Yamaguchi N

Neuropsychiatric Disease and Treatment 2013, 9:587-594

Published Date: 29 April 2013

Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer’s disease

Kato Y, Narumoto J, Matsuoka T, Okamura A, Koumi H, Kishikawa Y, Terashima S, Fukui K

Neuropsychiatric Disease and Treatment 2013, 9:581-586

Published Date: 30 April 2013

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression

Kamijima K, Hashimoto S, Nagayoshi E, Koyama T

Neuropsychiatric Disease and Treatment 2013, 9:555-565

Published Date: 26 April 2013

Role of oral teriflunomide in the management of multiple sclerosis

Tanasescu R, Evangelou N, Constantinescu CS

Neuropsychiatric Disease and Treatment 2013, 9:539-553

Published Date: 22 April 2013

Blended E-health module on return to work embedded in collaborative occupational health care for common mental disorders: design of a cluster randomized controlled trial

Volker D, Vlasveld MC, Anema JR, Beekman ATF, Hakkaart-van Roijen L, Brouwers EPM, van Lomwel AGC, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2013, 9:529-537

Published Date: 22 April 2013

Predicting PTSD using the New York Risk Score with genotype data: potential clinical and research opportunities

Boscarino JA, Kirchner HL, Hoffman SN, Erlich PM

Neuropsychiatric Disease and Treatment 2013, 9:517-527

Published Date: 15 April 2013

Psychosurgery for schizophrenia: history and perspectives

Soares MS, Paiva WS, Guertzenstein EZ, Amorim RL, Bernardo LS, Pereira JF, Fonoff ET, Teixeira MJ

Neuropsychiatric Disease and Treatment 2013, 9:509-515

Published Date: 15 April 2013

Worsened hypertension control induced by aripiprazole

Yasui-Furukori N, Fujii A

Neuropsychiatric Disease and Treatment 2013, 9:505-507

Published Date: 15 April 2013

Transcranial magnetic stimulation for treating depression in elderly patients

Hizli Sayar G, Ozten E, Tan O, Tarhan N

Neuropsychiatric Disease and Treatment 2013, 9:501-504

Published Date: 15 April 2013

Maturation of the adolescent brain

Arain M, Haque M, Johal L, Mathur P, Nel W, Rais A, Sandhu R, Sharma S

Neuropsychiatric Disease and Treatment 2013, 9:449-461

Published Date: 3 April 2013

Primary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter study

Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Mazzotta G, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:437-443

Published Date: 31 March 2013

Two diagnoses become one? Rare case report of anorexia nervosa and Cushing’s syndrome

Sawicka N, Gryczyńska M, Sowiński J, Tamborska-Zedlewska M, Ruchała M

Neuropsychiatric Disease and Treatment 2013, 9:431-435

Published Date: 31 March 2013

Neuropsychology of eating disorders: 1995–2012

Jáuregui-Lobera I

Neuropsychiatric Disease and Treatment 2013, 9:415-430

Published Date: 31 March 2013

Impact of nocturnal sleep deprivation on declarative memory retrieval in students at an orphanage: a psychoneuroradiological study

Tantawy AO, El Tallawy HN, Farghaly HRS, Farghaly WM, Hussein AS

Neuropsychiatric Disease and Treatment 2013, 9:403-408

Published Date: 27 March 2013

Depressive symptoms in Parkinson’s disease and in non-neurological medical illnesses

Assogna F, Fagioli S, Cravello L, Meco G, Pierantozzi M, Stefani A, Imperiale F, Caltagirone C, Pontieri FE, Spalletta G

Neuropsychiatric Disease and Treatment 2013, 9:389-396

Published Date: 21 March 2013

Personality disorders and treatment drop out in the homeless

Salavera C, Tricás JM, Lucha O

Neuropsychiatric Disease and Treatment 2013, 9:379-387

Published Date: 22 March 2013

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice

Bodén R, Edman G, Reutfors J, Östenson CG, Ösby U

Neuropsychiatric Disease and Treatment 2013, 9:371-377

Published Date: 19 March 2013

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US

Jara M, Barker G, Henney 3rd HR

Neuropsychiatric Disease and Treatment 2013, 9:365-370

Published Date: 10 March 2013

Treatment in a ward for elderly patients with dementia in Japan

Taniguchi S, Narumoto J, Shibata K, Ayani N, Matsuoka T, Okamura A, Nakamura K, Shimizu H, Fukui K

Neuropsychiatric Disease and Treatment 2013, 9:357-363

Published Date: 6 March 2013

Maternal stress and childhood migraine: a new perspective on management

Esposito M, Gallai B, Parisi L, Roccella M, Marotta R, Lavano SM, Gritti A, Mazzotta G, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:351-355

Published Date: 6 March 2013

Review: management of Parkinson's disease

Pedrosa DJ, Timmermann L

Neuropsychiatric Disease and Treatment 2013, 9:321-340

Published Date: 3 March 2013

Cognitive-behavioral therapy for body dysmorphic disorder: a review of its efficacy

Prazeres AM, Nascimento AL, Fontenelle LF

Neuropsychiatric Disease and Treatment 2013, 9:307-316

Published Date: 28 February 2013

Hypersomnia in children affected by migraine without aura: a questionnaire-based case-control study

Esposito M, Roccella M, Parisi L, Gallai B, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:289-294

Published Date: 21 February 2013

Group cognitive behavioral therapy for patients with generalized social anxiety disorder in Japan: outcomes at 1-year follow up and outcome predictors

Kawaguchi A, Watanabe N, Nakano Y, Ogawa S, Suzuki M, Kondo M, Furukawa TA, Akechi T

Neuropsychiatric Disease and Treatment 2013, 9:267-275

Published Date: 20 February 2013

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil

Kano O, Ito H, Takazawa T, Kawase Y, Murata K, Iwamoto K, Nagaoka T, Hirayama T, Miura K, Nagata R, Kiyozuka T, Aoyagi J, Sato R, Eguchi T, Ikeda K, Iwasaki Y

Neuropsychiatric Disease and Treatment 2013, 9:259-265

Published Date: 15 February 2013

Inpatient rehabilitation outcome: a matter of diagnosis?

Bejor M, Ramella FC, Dalla Toffola E, Comelli M, Chiappedi M

Neuropsychiatric Disease and Treatment 2013, 9:253-257

Published Date: 18 February 2013

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study

Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M, Colicchio S, Cattaneo CI, D'Angelo E, Fornaro P

Neuropsychiatric Disease and Treatment 2013, 9:243-251

Published Date: 15 February 2013

Mental health in migrant schoolchildren in Italy: teacher-reported behavior and emotional problems

Margari L, Pinto F, Lafortezza ME, Lecce PA, Craig F, Grattagliano I, Zagaria G, Margari F

Neuropsychiatric Disease and Treatment 2013, 9:231-241

Published Date: 11 February 2013

Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults

Ermer J, Haffey MB, Richards C, Lasseter K, Adeyi B, Corcoran M, Stanton B, Martin P

Neuropsychiatric Disease and Treatment 2013, 9:219-229

Published Date: 12 February 2013

Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study

Valdizán-Usón JR, Cánovas-Martínez A, De Lucas-Taracena M, Díaz-Atienza F, Eddy-Ives LS, Fernández-Jaén A, Fernández-Pérez M, García-Giral M, García-Magán P, Garraus-Oneca M, Idiazábal-Alecha MA, López-Benito M, Lorenzo-Sanz G, Martínez-Antón J, Martínez-Granero MA, Montañés-Rada F, Mulas-Delgado F, Ochando-Perales G, Ortega-García E, Pelaz-Antolín A, Ramos-Quiroga JA, Ruiz-Sanz FC, Vaquerizo-Madrid J, Yusta-Izquierdo A

Neuropsychiatric Disease and Treatment 2013, 9:211-218

Published Date: 8 February 2013

Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

Dell'Osso B, Arici C, Dobrea C, Camuri G, Benatti B, Altamura AC

Neuropsychiatric Disease and Treatment 2013, 9:205-209

Published Date: 8 February 2013

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study

Jeong JH, Bahk WM, Woo YS, Seo HJ, Hong SC, Jon DI, Min KJ, Yoon BH

Neuropsychiatric Disease and Treatment 2013, 9:197-204

Published Date: 8 February 2013

Editor’s choice: the best of 2011–2012

Pinder RM

Neuropsychiatric Disease and Treatment 2013, 9:195-196

Published Date: 8 February 2013

The relationship between alexithymia, shame, trauma, and body image disorders: investigation over a large clinical sample

Franzoni E, Gualandi S, Caretti V, Schimmenti A, Di Pietro E, Pellegrini G, Craparo G, Franchi A, Verrotti A, Pellicciari A

Neuropsychiatric Disease and Treatment 2013, 9:185-193

Published Date: 18 February 2013

Semantics, pragmatics, and formal thought disorders in people with schizophrenia

Salavera C, Puyuelo M, Antoñanzas JL, Teruel P

Neuropsychiatric Disease and Treatment 2013, 9:177-183

Published Date: 7 February 2013

Epidemiology and treatment of mood disorders in a day hospital setting from 1996 to 2007: an Italian study

Luca M, Prossimo G, Messina V, Luca A, Romeo S, Calandra C

Neuropsychiatric Disease and Treatment 2013, 9:169-176

Published Date: 7 February 2013

General versus executive cognitive ability in pupils with ADHD and with milder attention problems

Ek U, Westerlund J, Fernell E

Neuropsychiatric Disease and Treatment 2013, 9:163-168

Published Date: 29 January 2013

Acupressure therapy for insomnia in adolescents: a polysomnographic study

Carotenuto M, Gallai B, Parisi L, Roccella M, Esposito M

Neuropsychiatric Disease and Treatment 2013, 9:157-162

Published Date: 24 January 2013

Capgras-like syndrome in a patient with an acute urinary tract infection

Salviati M, Bersani FS, Macrì F, Fojanesi M, Minichino A, Gallo M, De Michele F, Delle Chiaie R, Biondi M

Neuropsychiatric Disease and Treatment 2013, 9:139-142

Published Date: 17 January 2013

Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis

Medic G, Higashi K, Littlewood KJ, Diez T, Granström O, Kahn RS

Neuropsychiatric Disease and Treatment 2013, 9:119-131

Published Date: 16 January 2013

Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia

Suttajit S, Srisurapanont M, Pilakanta S, Charnsil C, Suttajit S.

Neuropsychiatric Disease and Treatment 2013, 9:113-118

Published Date: 16 January 2013

Easy quantitative methodology to assess visual-motor skills

Chiappedi M, Toraldo A, Mandrini S, Scarpina F, Aquino M, Magnani FG, Bejor M

Neuropsychiatric Disease and Treatment 2013, 9:93-100

Published Date: 14 January 2013

Sensory integration dysfunction affects efficacy of speech therapy on children with functional articulation disorders

Tung LC, Lin CK, Hsieh CL, Chen CC, Huang CT, Wang CH

Neuropsychiatric Disease and Treatment 2013, 9:87-92

Published Date: 9 January 2013

Differential attentional bias in generalized anxiety disorder and panic disorder

Chen J, Wang Z, Wu Y, Cai Y, Shen Y, Wang L, Shi S

Neuropsychiatric Disease and Treatment 2013, 9:73-80

Published Date: 8 January 2013

Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome

Gürsoy AE, Kolukısa M, Babacan Yıldız G, Kocaman G, Çelebi A, Koçer A

Neuropsychiatric Disease and Treatment 2013, 9:65-71

Published Date: 7 January 2013

A review of the potential therapeutic role of statins in the treatment of Alzheimer’s disease: current research and opinion

Sánchez-Ferro A, Benito-León J, Mitchell AJ, Bermejo-Pareja F

Neuropsychiatric Disease and Treatment 2013, 9:55-63

Published Date: 4 January 2013

Self-reported psychopathology and health-related quality of life in heroin users treated with methadone

Chen YZ, Huang WL, Shan JC, Lin YH, Wu Chang HC, Chang LR

Neuropsychiatric Disease and Treatment 2013, 9:41-48

Published Date: 27 December 2012

Effects, experiences, and impact of stigma on patients with bipolar disorder

Mileva VR, Vázquez GH, Milev R

Neuropsychiatric Disease and Treatment 2013, 9:31-40

Published Date: 16 January 2013

Decreased white matter integrity before the onset of delusions in patients with Alzheimer's disease: diffusion tensor imaging

Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M

Neuropsychiatric Disease and Treatment 2013, 9:25-29

Published Date: 27 December 2012

Predictors of postpartum depression in a sample of Egyptian women

Saleh ES, El-Bahei W, El-Hadidy MA, Zayed A

Neuropsychiatric Disease and Treatment 2013, 9:15-24

Published Date: 21 December 2012

Behavior management approach for agitated behavior in Japanese patients with dementia: a pilot study

Sato J, Nakaaki S, Torii K, Oka M, Negi A, Tatsumi H, Narumoto J, Furukawa TA, Mimura M

Neuropsychiatric Disease and Treatment 2013, 9:9-14

Published Date: 21 December 2012

Neuroanatomical abnormalities before onset of delusions in patients with Alzheimer’s disease: a voxel-based morphometry study

Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M

Neuropsychiatric Disease and Treatment 2013, 9:1-8

Published Date: 21 December 2012